_
Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS Australia (SA) Inc
 
 
Facebook
 
ME/CFS AUSTRALIA (SA) INC

Registered Charity 3104

Email:
sacfs@sacfs.asn.au

Mailing address:

PO Box 322,
Modbury,
South Australia 5092

Phone:
1300 128 339

Office Hours:
Monday - Friday,
10am - 4pm
(phone)

ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
DOCX Application Form (PDF, 156KB)
Why become a member?

Research Teams Find Widespread Inflammation In The Brains Of Fibromyalgia Patients

Friday 28 September 2018

 

From EurekAlert:

 

MR/PET image
This combined MR/PET image highlights areas of the brain
in which patients with fibromyalgia were found to have
increased glial activation, compared with
unaffected control volunteers.
(Image: Marco Loggia, PhD, Martinos Center for
Biomedical Imaging, Massachusetts General Hospital
)
 

Research teams find widespread inflammation in the brains of fibromyalgia patients

Media Contact: Terri Ogan
PUBLIC RELEASE: 27-SEP-2018
Copyright © 2018 by the American Association for the Advancement of Science (AAAS)

PET imaging studies at Mass. General Hospital, Karolinska Institutet reveal elevated glial activation, correlation with fatigue levels

MASSACHUSETTS GENERAL HOSPITAL

A study by Massachusetts General Hospital (MGH) researchers - collaborating with a team at the Karolinska Institutet in Sweden - has documented for the first time widespread inflammation in the brains of patients with the poorly understood condition called fibromyalgia. Their report has been published online in the journal Brain, Behavior and Immunity.

"We don't have good treatment options for fibromyalgia, so identifying a potential treatment target could lead to the development of innovative, more effective therapies," says Marco Loggia, PhD, of the MGH-based Martinos Center for Biomedical Imaging, co-senior author of the report. "And finding objective neurochemical changes in the brains of patients with fibromyalgia should help reduce the persistent stigma that many patients face, often being told their symptoms are imaginary and there's nothing really wrong with them."

 

Full article…

 


Arrow right

More Fibromyalgia News

 


 

blog comments powered by Disqus
Previous Previous Page